🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Biosimilar Collaborations Ireland Limited — Licensed Medicines

19 medicines held by Biosimilar Collaborations Ireland Limited on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 19 products held by Biosimilar Collaborations Ireland Limited
MedicineActive substanceLicence holderStatus
Abevmy 25 mg/mL concentrate for solution for infusion
EU/1/20/1515/001-005
Bevacizumab Biosimilar Collaborations Ireland Limited
Evfraxy 60 mg solution for injection in pre-filled syringe
EU/1/25/1946/001
Denosumab Biosimilar Collaborations Ireland Limited
Fulphila 6 mg solution for injection in pre-filled syringe
EU/1/18/1329/001-002
Pegfilgrastim Biosimilar Collaborations Ireland Limited
Hulio
EU/1/18/1319/001-007
Adalimumab Biosimilar Collaborations Ireland Limited
Hulio 20 mg solution for injection in pre-filled syringe
EU/1/18/1319/009-010
Adalimumab Biosimilar Collaborations Ireland Limited
Kirsty
EU/1/20/1506/001-007
Insulin aspart Biosimilar Collaborations Ireland Limited
Nepexto 25 mg solution for injection in pre-filled syringe
EU/1/20/1436/001-002
Etanercept Biosimilar Collaborations Ireland Limited
Nepexto 50 mg solution for injection in pre-filled pen
EU/1/20/1436/005-006
Etanercept Biosimilar Collaborations Ireland Limited
Nepexto 50 mg solution for injection in pre-filled syringe
EU/1/20/1436/003-004
Etanercept Biosimilar Collaborations Ireland Limited
Ogivri 150 mg powder for concentrate for solution for infusion
EU/1/18/1341/001
Trastuzumab Biosimilar Collaborations Ireland Limited
Ogivri 420 mg powder for concentrate for solution for infusion
EU/1/18/1341/002
Trastuzumab Biosimilar Collaborations Ireland Limited
Semglee 100 units/ml solution for injection in pre-filled pen
EU/1/18/1270/001-004
Insulin glargine Biosimilar Collaborations Ireland Limited
Vevzuo 120 mg solution for injection
EU/1/25/1945/001-003
Denosumab Biosimilar Collaborations Ireland Limited
Vivlipeg 6 mg solution for injection in pre-filled syringe
EU/1/25/1967/001-002
Pegfilgrastim Biosimilar Collaborations Ireland Limited
Yesafili 40 mg/mL solution for injection in pre-filled syringe.
EU/1/23/1751/001-002
Aflibercept Biosimilar Collaborations Ireland Limited
Yesintek 130 mg Concentrate for solution for infusion
EU/1/24/1892/004
Ustekinumab Biosimilar Collaborations Ireland Limited
Yesintek 45 mg Solution for injection
EU/1/24/1892/002
Ustekinumab Biosimilar Collaborations Ireland Limited
Yesintek 45 mg Solution for injection Subcutaneous use
EU/1/24/1892/001
Ustekinumab Biosimilar Collaborations Ireland Limited
Yesintek 90 mg Solution for injection
EU/1/24/1892/003
Ustekinumab Biosimilar Collaborations Ireland Limited
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.